Abbott Atrial Fibrillation Post Approval Study
Public ClinicalTrials.gov record NCT05434650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This post-approval study is designed to provide continued real-world clinical evidence to confirm the safety and long-term effectiveness of atrial fibrillation (AF) radiofrequency (RF) technologies (e.g. TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE)) for the treatment of AF.
Study identification
- NCT ID
- NCT05434650
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 200 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 21, 2022 (Actual)
- Primary completion
- Oct 22, 2024 (Actual)
- Completion
- Nov 30, 2026 (Estimated)
- Last update posted
- Nov 19, 2025
2022 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Heart Center Research, LLC. | Huntsville | Alabama | 35801 | — |
| Arkansas Cardiology | Little Rock | Arkansas | 72205 | — |
| Eisenhower Medical Center | Rancho Mirage | California | 92270 | — |
| Sequoia Hospital | Redwood City | California | 94062 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| Brigham & Women's Hospital | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Providence Hospital | Southfield | Michigan | 48075 | — |
| North Mississippi Medical Center | Tupelo | Mississippi | 38801 | — |
| St. Patrick Hospital | Missoula | Montana | 59802 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Oklahoma Heart Hospital South | Oklahoma City | Oklahoma | 73135 | — |
| Doylestown Hospital | Doylestown | Pennsylvania | 18901 | — |
| Erlanger Medical Center | Chattanooga | Tennessee | 37403 | — |
| Centennial Medical Center | Nashville | Tennessee | 37203 | — |
| Methodist Hospital of San Antonio | San Antonio | Texas | 78229 | — |
| St. Marks Hospital | Salt Lake City | Utah | 84124 | — |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | — |
| Chippenham Hospital | Richmond | Virginia | 23225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05434650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05434650 live on ClinicalTrials.gov.